Skip to Content
Merck
  • Development of a repressible mycobacterial promoter system based on two transcriptional repressors.

Development of a repressible mycobacterial promoter system based on two transcriptional repressors.

Nucleic acids research (2010-04-22)
Francesca Boldrin, Stefano Casonato, Elisa Dainese, Claudia Sala, Neeraj Dhar, Giorgio Palù, Giovanna Riccardi, Stewart T Cole, Riccardo Manganelli
ABSTRACT

Tightly regulated gene expression systems represent invaluable tools for studying gene function and for the validation of drug targets in bacteria. While several regulated bacterial promoters have been characterized, few of them have been successfully used in mycobacteria. In this article we describe the development of a novel repressible promoter system effective in both fast- and slow-growing mycobacteria based on two chromosomally encoded repressors, dependent on tetracycline (TetR) and pristinamycin (Pip), respectively. This uniqueness results in high versatility and stringency. Using this method we were able to obtain an ftsZ conditional mutant in Mycobacterium smegmatis and a fadD32 conditional mutant in Mycobacterium tuberculosis, confirming their essentiality for bacterial growth in vitro. This repressible promoter system could also be exploited to regulate gene expression during M. tuberculosis intracellular growth.

MATERIALS
Product Number
Brand
Product Description

Supelco
4-Epianhydrotetracycline hydrochloride, VETRANAL®, analytical standard
Supelco
Anhydrotetracycline hydrochloride, VETRANAL®, analytical standard